PPD
PPD
#1290
Rank
NZ$28.72 B
Marketcap
NZ$81.76
Share price
0.00%
Change (1 day)
14,611.36%
Change (1 year)
PPD, Inc. or Pharmaceutical Product Development is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services.

Revenue for PPD (PPD)

Revenue in 2021 (TTM): NZ$8.37 Billion

According to PPD's latest financial reports the company's current revenue is NZ$10.16 Billion. In 2020 the company made a revenue of NZ$8.09 Billion an increase over the revenue in the year 2019 that were of NZ$6.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PPD from 2019 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)NZ$8.37 B3.51%
2020NZ$8.09 B16.14%
2019NZ$6.97 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA